Study of brain activity during thinking using electrode recordings
Treatments studied
Part of Mental health clinical trials.
This Phase 1 study records electrical signals from the brain while you perform thinking tasks. The goal is to better understand how human brain circuits work during cognition, and the study may help future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years old).
- You are currently an inpatient in the neuro unit at Stanford Medical Center.
- If you are female, you must not be pregnant and must use reliable birth control during the study (or abstain).
- You do not have a lifetime history of a psychotic disorder.
- You are not pregnant and not nursing.
- You have not had ketamine in the past 7 days and have not had a bad reaction to ketamine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how ketamine changes “dissociative” experiences—feelings of being disconnected from thoughts or surroundings—in adults. You may be helping researchers better understand ketamine’s effects, which could guide safer future uses.
This study tests if adding computer-based cognitive training to ketamine treatment can improve mood in people with depression that hasn't responded to other treatments. It aims to see if the combination works better than ketamine alone.
This study tests whether a single dose of ketamine can help people with anorexia nervosa learn new ways of thinking about food and body image during recovery. You may be eligible if you are a teenager or young adult currently hospitalized for malnutrition.
This trial studies how ketamine affects the brain in people dealing with suicidal thoughts or an active suicide crisis. It uses questionnaires, consent testing, and brain imaging to look for biological changes that may relate to symptom improvement.
This early-stage study tests ketamine and looks at what brain changes may explain why it helps people with major depression that hasn’t improved with usual treatments. You may be asked to stay in the hospital and complete detailed interviews, mood rating scales, and brain imaging.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
Hear when a new Psychiatric Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.